← Back to Search

ALL App Literacy Program for Children

N/A
Waitlist Available
Led By Jessica Caron, Ph.D.
Research Sponsored by Penn State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 8 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a literacy program for kids with limited or no speech to help them learn & develop literacy skills.

Who is the study for?
This trial is for English-speaking and reading school support personnel working with children aged 3-8 who use AAC due to speech challenges. The children should have limited literacy skills, not be receiving consistent phonics-based instruction, and must have access to an iPad.
What is being tested?
The study tests a literacy app called Accessible Literacy Learning (ALL). It compares the effectiveness of ALL Sight Word Instruction versus ALL Phonics Instruction on improving literacy in children using AAC over 100 lessons.
What are the potential side effects?
There are no medical side effects associated with this trial as it involves educational interventions. However, participants may experience varying degrees of engagement or frustration depending on their individual responses to the learning material.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline Scores on the Early Literacy Assessment
Secondary study objectives
Data from the Feasibility Adoption Acceptability Questionnaire (FAAQ)
Treatment and Acceptability Rating Form - Revised

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ALL Phonics InstructionExperimental Treatment1 Intervention
Lessons for the treatment group will be 30-min. long using the ALL app with a known service provider. Lessons will include systematic instruction with four subskills per session (e.g., letter-sounds, sound blending, typing, and sight words). The words and subskills with rotate based on the data collected and the machine learning within the technology. The child will complete 100 lessons. The systematic instruction with subksills (e.g., sound blending, decoding) includes 10 trials per word and an instructional sequence that introduces the skill, two models, six trials of guided practice, and two trials of independent practice with corrective feedback.
Group II: ALL Sight WordActive Control1 Intervention
Lessons for the comparison group will be 30-min. long using the ALL app with a known service provider. Lessons will include systematic instruction with sight words. The child will also complete 100 lessons.No phonics instruction will be provided to this group through the ALL app.

Find a Location

Who is running the clinical trial?

Penn State UniversityLead Sponsor
370 Previous Clinical Trials
127,955 Total Patients Enrolled
Jessica Caron, Ph.D.Principal InvestigatorThe Pennsylvania State University

Media Library

ALL Phonics Instruction Clinical Trial Eligibility Overview. Trial Name: NCT05602181 — N/A
ALL Phonics Instruction 2023 Treatment Timeline for Medical Study. Trial Name: NCT05602181 — N/A
Literacy Research Study Groups: ALL Phonics Instruction, ALL Sight Word
Literacy Clinical Trial 2023: ALL Phonics Instruction Highlights & Side Effects. Trial Name: NCT05602181 — N/A
~8 spots leftby Jun 2025